Yiming Lin

652 total citations
44 papers, 395 citations indexed

About

Yiming Lin is a scholar working on Clinical Biochemistry, Molecular Biology and Rheumatology. According to data from OpenAlex, Yiming Lin has authored 44 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Clinical Biochemistry, 31 papers in Molecular Biology and 13 papers in Rheumatology. Recurrent topics in Yiming Lin's work include Metabolism and Genetic Disorders (33 papers), Mitochondrial Function and Pathology (15 papers) and Folate and B Vitamins Research (13 papers). Yiming Lin is often cited by papers focused on Metabolism and Genetic Disorders (33 papers), Mitochondrial Function and Pathology (15 papers) and Folate and B Vitamins Research (13 papers). Yiming Lin collaborates with scholars based in China, Saudi Arabia and United States. Yiming Lin's co-authors include Weihua Lin, Zhenzhu Zheng, Weilin Peng, Chunmei Lin, Xinwen Huang, Dongmei Chen, Chenggang Huang, Chao Zhang, Qingqing Ma and Xinyi Song and has published in prestigious journals such as PLoS ONE, Clinica Chimica Acta and Food Control.

In The Last Decade

Yiming Lin

42 papers receiving 368 citations

Peers

Yiming Lin
Bijina Balakrishnan United States
Kerry L. Ross United States
Daniel Bürgisser Switzerland
Christian J. Madson United States
Wanqiong Qiao United States
Yiming Lin
Citations per year, relative to Yiming Lin Yiming Lin (= 1×) peers Bianca T. van Maldegem

Countries citing papers authored by Yiming Lin

Since Specialization
Citations

This map shows the geographic impact of Yiming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Lin more than expected).

Fields of papers citing papers by Yiming Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Lin. The network helps show where Yiming Lin may publish in the future.

Co-authorship network of co-authors of Yiming Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yiming Lin. A scholar is included among the top collaborators of Yiming Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiming Lin. Yiming Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Jianhua, Yuetong Li, Yang Liu, et al.. (2025). Hepatitis B virus X protein (HBx)-mediated immune modulation and prognostic model development in hepatocellular carcinoma. PLoS ONE. 20(6). e0325363–e0325363. 1 indexed citations
2.
Zeng, Yanjun, Xirui Chen, Hongyan Li, et al.. (2024). Evaluation of the ability of large language models to self-diagnose oral diseases. iScience. 27(12). 111495–111495. 3 indexed citations
3.
Lin, Yiming, Zhenzhu Zheng, Weihua Lin, & Weilin Peng. (2024). Incorporating Next‐Generation Sequencing as a Second‐Tier Test for Primary Carnitine Deficiency. Molecular Genetics & Genomic Medicine. 12(9). 1 indexed citations
4.
Lin, Yiming, et al.. (2024). Rapid detection of common variants and deletions of CYP21A2 using MALDI-TOF MS. European Journal of Medical Genetics. 69. 104950–104950.
5.
Lin, Weihua, et al.. (2024). Newborn screening and genetic diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency in Quanzhou,China. Molecular Genetics and Metabolism Reports. 40. 101127–101127. 1 indexed citations
6.
Lin, Weihua, et al.. (2023). Clinical and genetic analysis of 26 Chinese patients with neonatal intrahepatic cholestasis due to citrin deficiency. Clinica Chimica Acta. 552. 117617–117617. 4 indexed citations
7.
Lin, Yiming, et al.. (2022). Incorporating second-tier genetic screening for multiple acyl-CoA dehydrogenase deficiency. Clinica Chimica Acta. 537. 181–187. 4 indexed citations
8.
Lin, Yiming, et al.. (2022). Newborn screening and genetic features of patients with hyperphenylalaninemia in a southern Chinese population. Clinica Chimica Acta. 535. 13–18. 6 indexed citations
9.
Zhang, Weifeng, Xiaogang Li, Yiming Lin, et al.. (2021). A novel synonymous ABCA3 variant identified in a Chinese family with lethal neonatal respiratory failure. BMC Medical Genomics. 14(1). 256–256. 5 indexed citations
10.
Lin, Yiming, Dongmei Chen, Weilin Peng, et al.. (2020). Newborn screening for isovaleric acidemia in Quanzhou, China. Clinica Chimica Acta. 509. 25–29. 8 indexed citations
11.
Lin, Yiming, et al.. (2020). Combined primary carnitine deficiency with neonatal intrahepatic cholestasis caused by citrin deficiency in a Chinese newborn. BMC Pediatrics. 20(1). 478–478. 5 indexed citations
12.
Zheng, Zhenzhu, et al.. (2020). Clinical, biochemical, and genetic analysis of a Chinese Han pedigree with holocarboxylase synthetase deficiency: a case report. BMC Medical Genetics. 21(1). 155–155. 3 indexed citations
13.
Lin, Yiming, Hao Xu, Chao Zhang, et al.. (2020). Screening 3.4 million newborns for primary carnitine deficiency in Zhejiang Province, China. Clinica Chimica Acta. 507. 199–204. 28 indexed citations
14.
Lin, Weihua, Zhenzhu Zheng, Yanru Chen, et al.. (2020). Newborn screening for primary carnitine deficiency in Quanzhou, China. Clinica Chimica Acta. 512. 166–171. 10 indexed citations
15.
Lin, Yiming, Dongmei Chen, Chunmei Lin, et al.. (2020). Newborn screening and genetic characteristics of patients with short- and very long-chain acyl-CoA dehydrogenase deficiencies. Clinica Chimica Acta. 510. 285–290. 3 indexed citations
16.
Lin, Yiming, Hongzhi Gao, Bin Lü, et al.. (2019). Citrullinemia type I is associated with a novel splicing variant, c.773 + 4A > C, in ASS1: a case report and literature review. BMC Medical Genetics. 20(1). 110–110. 6 indexed citations
17.
Lin, Yiming, et al.. (2019). A prenatal diagnosis and genetics study of five pedigrees in the Chinese population with Xp22.31 microduplication. Molecular Cytogenetics. 12(1). 50–50. 13 indexed citations
18.
Lin, Yiming, et al.. (2018). Mild clinical features of isolated methylmalonic acidemia associated with a novel variant in the MMAA gene in two Chinese siblings. BMC Medical Genetics. 19(1). 114–114. 6 indexed citations
19.
Lin, Yiming, Weilin Peng, Mengyi Jiang, et al.. (2018). Clinical, biochemical and genetic analysis of Chinese patients with isobutyryl-CoA dehydrogenase deficiency. Clinica Chimica Acta. 487. 133–138. 20 indexed citations
20.
Yang, Lily, Zehong Cao, Yiming Lin, William C. Wood, & Charles A. Staley. (2005). Molecular beacon imaging of tumor marker gene expression in pancreatic cancer cell. Cancer Biology & Therapy. 4(5). 561–570. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026